Clinical Efficacy and Safety of Tevagrastim® (XM02), a Biosimilar Recombinant Human Granulocyte Colony-Stimulating Factor

Biosimilars
doi 10.2147/bs.s27712
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited


Related search